Cavion

Q: What is Cavion's official website?

Cavion's official website is www.cavionpharma.com

Q: What is Cavion's Revenue?

Cavion's revenue is <$5 Million

Q: What industry does Cavion belong to?

Cavion is in the industry of: Manufacturing , Pharmaceuticals , Business Services

Q: What is Cavion competition?

Cavion top competitors include: Trevena , Lipella Pharmaceuticals , Revalesio , NuvOx Pharma

Q: What companies has Cavion acquired?

Cavion has acquired the companies: Celator Pharmaceuticals, GW Pharmaceuticals, Orphan Medical, Actio

Q: What technology does Cavion use?

Some of the popular technologies that Cavion uses are: Google Universal Analytics, Adobe Typekit, Microsoft 365, Liquidweb

Q: How do I contact Cavion?

Cavion contact info: Phone number: (434) 200-8442 Website: www.cavionpharma.com

Q: What does Cavion do?

Cavion, based in Charlottesville, VA and Cambridge, MA, a clinical-stage biotechnology company and now a wholly-owned subsidiary of Jazz, focuses on therapies aimed at modulating the T-type calcium channel for the treatment of chronic and rare neurological diseases. Cavion's portfolio of T-type calcium channel modulators is being developed to resto... re the brain's natural rhythms in a variety of neurological diseases such as essential tremor, Parkinson's disease tremor, neuropathic pain, and epilepsy with absence seizures. Read More

Q: Who invested in Cavion?

Cavion has 4 investors including Novartis Venture Fund, Enso Ventures and Lilly Ventures.

Q: Is Cavion a public company?

Cavion is private company therefore does not currently have an official ticker symbol

Manufacturing · Virginia, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

600 E Water St Ste E, Charlottesville, V...

Phone Number

(434) 200-8442

Website

www.cavionpharma.com

Revenue

<$5 Million

Industry

Manufacturing

Pharmaceuticals

Business Services

Research & Development

About Cavion

Cavion, based in Charlottesville, VA and Cambridge, MA, a clinical-stage biotechnology company and now a wholly-owned subsidiary of Jazz, focuses on therapies aimed at modulating the T-type calcium channel for the treatment of chronic and rare neurological diseases. Cavion's portfolio of T-type calcium channel modulators is being developed to restore the brain's natural rhythms in a variety of neurological diseases such as essential tremor, Parkinson's disease tremor, neuropathic pain, and epilepsy with absence seizures.Explore more

Is this data correct?

View contact profiles from Cavion

SIC Code 28,283NAICS Code 32,325Show more

Cavion Org Chart

Phone

Stacey Boyer

Vice President, Clinical Research Operations

Phone

Get the full picture

Compare Similar Companies to Cavion

Compare insights from companies similar to Cavion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.